Search results for PX-TA1298
Showing 1 – 10 of1products
ID: BAB993548829
Ocaratuzumab Biosimilar – Anti-MS4A1, CD20 mAb – Research Grade, ProteoGenix, PX-TA1298
Description of Ocaratuzumab Biosimilar - Anti-MS4A1, CD20 mAb - Research Grade General information on Anti-MS4A1/CD20[Homo sapiens] (Ocaratuzumab) Monoclonal Antibody Ocaratuzumab is used for the treatment of cancer and autoimmune disorders. The antibody has been designed with an increased affinity to the CD20 antigen on B-lymphocytes, to enhance antibody-dependent cell-mediated cytotoxicity (ADCC).
Host
Reactivity
Applications
Conjugation
Request a product
Please provide the required information below so that we can quickly source your products.